PPD, INC. has sponsored the creation of one or more 401k plans.
Additional information about PPD, INC.
Submission information for form 5500 for 401k plan PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN
401k plan membership statisitcs for PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN
| Measure | Date | Value |
|---|
| 2022: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2022 401k membership |
|---|
| Total participants, beginning-of-year | 2022-01-01 | 12,926 |
| Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 0 |
| Number of retired or separated participants receiving benefits | 2022-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 0 |
| Total of all active and inactive participants | 2022-01-01 | 0 |
| Number of employers contributing to the scheme | 2022-01-01 | 0 |
| 2021: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2021 401k membership |
|---|
| Total participants, beginning-of-year | 2021-01-01 | 11,249 |
| Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 12,926 |
| Number of retired or separated participants receiving benefits | 2021-01-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 0 |
| Total of all active and inactive participants | 2021-01-01 | 12,926 |
| 2020: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2020 401k membership |
|---|
| Total participants, beginning-of-year | 2020-01-01 | 9,779 |
| Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 11,249 |
| Total of all active and inactive participants | 2020-01-01 | 11,249 |
| 2019: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2019 401k membership |
|---|
| Total participants, beginning-of-year | 2019-01-01 | 9,244 |
| Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 9,779 |
| Total of all active and inactive participants | 2019-01-01 | 9,779 |
| 2018: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2018 401k membership |
|---|
| Total participants, beginning-of-year | 2018-01-01 | 8,563 |
| Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 9,089 |
| Number of retired or separated participants receiving benefits | 2018-01-01 | 118 |
| Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 37 |
| Total of all active and inactive participants | 2018-01-01 | 9,244 |
| 2017: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2017 401k membership |
|---|
| Total participants, beginning-of-year | 2017-01-01 | 8,272 |
| Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 8,535 |
| Number of retired or separated participants receiving benefits | 2017-01-01 | 162 |
| Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 82 |
| Total of all active and inactive participants | 2017-01-01 | 8,779 |
| 2016: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2016 401k membership |
|---|
| Total participants, beginning-of-year | 2016-01-01 | 7,387 |
| Total number of active participants reported on line 7a of the Form 5500 | 2016-01-01 | 8,034 |
| Number of retired or separated participants receiving benefits | 2016-01-01 | 69 |
| Number of other retired or separated participants entitled to future benefits | 2016-01-01 | 109 |
| Total of all active and inactive participants | 2016-01-01 | 8,212 |
| 2015: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2015 401k membership |
|---|
| Total participants, beginning-of-year | 2015-01-01 | 6,764 |
| Total number of active participants reported on line 7a of the Form 5500 | 2015-01-01 | 7,280 |
| Number of retired or separated participants receiving benefits | 2015-01-01 | 66 |
| Number of other retired or separated participants entitled to future benefits | 2015-01-01 | 133 |
| Total of all active and inactive participants | 2015-01-01 | 7,479 |
| 2014: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2014 401k membership |
|---|
| Total participants, beginning-of-year | 2014-01-01 | 6,351 |
| Total number of active participants reported on line 7a of the Form 5500 | 2014-01-01 | 6,587 |
| Number of retired or separated participants receiving benefits | 2014-01-01 | 77 |
| Total of all active and inactive participants | 2014-01-01 | 6,664 |
| 2013: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2013 401k membership |
|---|
| Total participants, beginning-of-year | 2013-01-01 | 6,081 |
| Total number of active participants reported on line 7a of the Form 5500 | 2013-01-01 | 6,302 |
| Number of retired or separated participants receiving benefits | 2013-01-01 | 4 |
| Number of other retired or separated participants entitled to future benefits | 2013-01-01 | 0 |
| Total of all active and inactive participants | 2013-01-01 | 6,306 |
| 2012: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2012 401k membership |
|---|
| Total participants, beginning-of-year | 2012-01-01 | 5,652 |
| Total number of active participants reported on line 7a of the Form 5500 | 2012-01-01 | 6,080 |
| Number of retired or separated participants receiving benefits | 2012-01-01 | 1 |
| Total of all active and inactive participants | 2012-01-01 | 6,081 |
| 2011: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2011 401k membership |
|---|
| Total participants, beginning-of-year | 2011-01-01 | 5,361 |
| Total number of active participants reported on line 7a of the Form 5500 | 2011-01-01 | 5,642 |
| Number of retired or separated participants receiving benefits | 2011-01-01 | 10 |
| Total of all active and inactive participants | 2011-01-01 | 5,652 |
| 2009: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2009 401k membership |
|---|
| Total participants, beginning-of-year | 2009-07-01 | 5,849 |
| Total number of active participants reported on line 7a of the Form 5500 | 2009-07-01 | 5,306 |
| Number of retired or separated participants receiving benefits | 2009-07-01 | 45 |
| Number of other retired or separated participants entitled to future benefits | 2009-07-01 | 45 |
| Total of all active and inactive participants | 2009-07-01 | 5,396 |
| 2022: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2022 form 5500 responses |
|---|
| 2022-01-01 | Type of plan entity | Single employer plan |
| 2022-01-01 | This submission is the final filing | Yes |
| 2022-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2022-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2021: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2021 form 5500 responses |
|---|
| 2021-01-01 | Type of plan entity | Single employer plan |
| 2021-01-01 | Submission has been amended | No |
| 2021-01-01 | This submission is the final filing | No |
| 2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2021-01-01 | Plan is a collectively bargained plan | No |
| 2021-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2021-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2020: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2020 form 5500 responses |
|---|
| 2020-01-01 | Type of plan entity | Single employer plan |
| 2020-01-01 | Submission has been amended | Yes |
| 2020-01-01 | This submission is the final filing | No |
| 2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2020-01-01 | Plan is a collectively bargained plan | No |
| 2020-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2020-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2019: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2019 form 5500 responses |
|---|
| 2019-01-01 | Type of plan entity | Single employer plan |
| 2019-01-01 | Submission has been amended | No |
| 2019-01-01 | This submission is the final filing | No |
| 2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2019-01-01 | Plan is a collectively bargained plan | No |
| 2019-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2019-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2018: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2018 form 5500 responses |
|---|
| 2018-01-01 | Type of plan entity | Single employer plan |
| 2018-01-01 | Submission has been amended | No |
| 2018-01-01 | This submission is the final filing | No |
| 2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2018-01-01 | Plan is a collectively bargained plan | No |
| 2018-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2018-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2017: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2017 form 5500 responses |
|---|
| 2017-01-01 | Type of plan entity | Single employer plan |
| 2017-01-01 | Submission has been amended | No |
| 2017-01-01 | This submission is the final filing | No |
| 2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2017-01-01 | Plan is a collectively bargained plan | No |
| 2017-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2017-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2016: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2016 form 5500 responses |
|---|
| 2016-01-01 | Type of plan entity | Single employer plan |
| 2016-01-01 | Submission has been amended | No |
| 2016-01-01 | This submission is the final filing | No |
| 2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2016-01-01 | Plan is a collectively bargained plan | No |
| 2016-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2016-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2015: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2015 form 5500 responses |
|---|
| 2015-01-01 | Type of plan entity | Single employer plan |
| 2015-01-01 | Submission has been amended | No |
| 2015-01-01 | This submission is the final filing | No |
| 2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2015-01-01 | Plan is a collectively bargained plan | No |
| 2015-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2015-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2014: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2014 form 5500 responses |
|---|
| 2014-01-01 | Type of plan entity | Single employer plan |
| 2014-01-01 | Submission has been amended | No |
| 2014-01-01 | This submission is the final filing | No |
| 2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2014-01-01 | Plan is a collectively bargained plan | No |
| 2014-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2014-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2013: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2013 form 5500 responses |
|---|
| 2013-01-01 | Type of plan entity | Mulitple employer plan |
| 2013-01-01 | Submission has been amended | No |
| 2013-01-01 | This submission is the final filing | No |
| 2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2013-01-01 | Plan is a collectively bargained plan | No |
| 2013-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2013-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2012: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2012 form 5500 responses |
|---|
| 2012-01-01 | Type of plan entity | Single employer plan |
| 2012-01-01 | Submission has been amended | No |
| 2012-01-01 | This submission is the final filing | No |
| 2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2012-01-01 | Plan is a collectively bargained plan | No |
| 2012-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2012-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2011: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2011 form 5500 responses |
|---|
| 2011-01-01 | Type of plan entity | Single employer plan |
| 2011-01-01 | Submission has been amended | No |
| 2011-01-01 | This submission is the final filing | No |
| 2011-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2011-01-01 | Plan is a collectively bargained plan | No |
| 2011-01-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2011-01-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
| 2009: PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. SEVERANCE PLAN 2009 form 5500 responses |
|---|
| 2009-07-01 | Type of plan entity | Single employer plan |
| 2009-07-01 | First time form 5500 has been submitted | Yes |
| 2009-07-01 | Submission has been amended | No |
| 2009-07-01 | This submission is the final filing | No |
| 2009-07-01 | This return/report is a short plan year return/report (less than 12 months) | Yes |
| 2009-07-01 | Plan is a collectively bargained plan | No |
| 2009-07-01 | Plan funding arrangement – General assets of the sponsor | Yes |
| 2009-07-01 | Plan benefit arrangement – General assets of the sponsor | Yes |
